Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.3.3 was added to the history and the footer links were updated to remove HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedNew revision v3.3.2 was added to the Record History and revision v3.2.0 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe government funding notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check64 days agoChange DetectedThe latest version updates core study details including recruitment status, study status, study design, and contact/locations. This affects how users track trial progress and locate study sites.SummaryDifference0.1%

- Check93 days agoChange DetectedMajor update to page content reflecting current operating status and a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference13%

- Check100 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.3%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.